Skip to main content
Article thumbnail
Location of Repository

Phagocytosis of Staphylococcus aureus by Macrophages Exerts Cytoprotective Effects Manifested by the Upregulation of Antiapoptotic Factors

By Joanna Koziel, Agnieszka Maciag-Gudowska, Tomasz Mikolajczyk, Malgorzata Bzowska, Daniel E. Sturdevant, Adeline R. Whitney, Lindsey N. Shaw, Frank R. DeLeo and Jan Potempa


It is becoming increasingly apparent that Staphylococcus aureus are able to survive engulfment by macrophages, and that the intracellular environment of these host cells, which is essential to innate host defenses against invading microorganisms, may in fact provide a refuge for staphylococcal survival and dissemination. Based on this, we postulated that S. aureus might induce cytoprotective mechanisms by changing gene expression profiles inside macrophages similar to obligate intracellular pathogens, such as Mycobacterium tuberculosis. To validate our hypothesis we first ascertained whether S. aureus infection could affect programmed cell death in human (hMDMs) and mouse (RAW 264.7) macrophages and, specifically, protect these cells against apoptosis. Our findings indicate that S. aureus-infected macrophages are more resistant to staurosporine-induced cell death than control cells, an effect partly mediated via the inhibition of cytochrome c release from mitochondria. Furthermore, transcriptome analysis of human monocyte-derived macrophages during S. aureus infection revealed a significant increase in the expression of antiapoptotic genes. This was confirmed by quantitative RT-PCR analysis of selected genes involved in mitochondria-dependent cell death, clearly showing overexpression of BCL2 and MCL1. Cumulatively, the results of our experiments argue that S. aureus is able to induce a cytoprotective effect in macrophages derived from different mammal species, which can prevent host cell elimination, and thus allow intracellular bacterial survival. Ultimately, it is our contention that this process may contribute to the systemic dissemination of S. aureus infection

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2009). A new pathway of staphylococcal pathogenesis: Apoptosis-like death induced by Staphopain B (SspB) in human peripheral blood neutrophils and monocytes.
    2. (2008). A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages.
    3. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.
    4. (2006). Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus.
    5. (1996). Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria.
    6. (1993). B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40.
    7. (2003). Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils.
    8. (1998). Bax directly induces release of cytochrome c from isolated mitochondria.
    9. (2000). Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.
    10. (2005). Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis.
    11. (2003). Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases.
    12. (2001). Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells.
    13. (2000). Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1).
    14. (2005). Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.
    15. (1996). Constitutive expression of the machinery for programmed cell death.
    16. (2001). Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages: Role of Mcl-1, independent of Nuclear Factor (NF)-B, Bad, or caspase activation.
    17. (2009). Corruption of innate immunity by bacterial proteases.
    18. (1998). Death receptors: signaling and modulation.
    19. (2003). Death receptors.
    20. (2007). Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells.
    21. (2008). Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen.
    22. (1995). Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation.
    23. (1994). From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation.
    24. (2007). GIMAP5 regulates mitochondrial integrity from a distinct subcellular compartment.
    25. (2004). Gonococcal porin IB activates NF-kappaB in human urethral epithelium and increases the expression of host antiapoptotic factors.
    26. (2004). Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2.
    27. (2002). Human macrophage activation programs induced by bacterial pathogens.
    28. (2004). Identification of caspase-10 in human neutrophils and its role in spontaneous apoptosis.
    29. (2005). Incomplete activation of macrophage apoptosis during intracellular replication of Legionella pneumophila.
    30. (1998). Inhibition by Porphyromonas gingivalis LPS of apoptosis induction in human peripheral blood polymorphonuclear leukocytes.
    31. (1997). Inhibition of death receptor signals by cellular FLIP.
    32. (2001). Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis.
    33. (2006). Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival.
    34. (2005). Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils.
    35. (1995). Internalization of Staphylococcus aureus by cultured osteoblasts.
    36. (1998). Internalization of Staphylococcus aureus by endothelial cells induces apoptosis.
    37. (2006). Intracellular replication of Edwardsiella tarda in murine macrophage is dependent on the type III secretion system and indicates an up-regulation of anti-apoptotic NF-kappaB target genes protecting the macrophages from staurosporineinduced apoptosis.
    38. (1998). Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells.
    39. (2000). Is Staphylococcus aureus an intracellular pathogen?
    40. (1998). Karsan A
    41. (2007). Legionella pneumophila inhibits macrophage apoptosis by targeting pro-death members of the Bcl2 protein family.
    42. (2004). Leishmania major-mediated prevention of programmed cell death induction in infected macrophages is associated with the repression of mitochondrial release of cytochrome c.
    43. (1991). Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes.
    44. (1997). Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions.
    45. (1996). MCL-1, a member of the BCL-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation.
    46. (1998). Mitochondria and apoptosis.
    47. (2000). Mitochondria as the central control point of apoptosis.
    48. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.
    49. (2002). Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs).
    50. (2004). NF-kappaB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and anti-apoptotic proteins.
    51. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.
    52. (1994). Programmed cell death: a fundamental protective response to pathogens.
    53. (2008). RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis.
    54. (2001). Salmonella-induced macrophage death: the role of caspase-1 in death and inflammation.
    55. (1992). Shigella flexneri induces apoptosis in infected macrophages.
    56. (2007). Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1.
    57. (1998). Staphylococcus aureus infections.
    58. (1998). Staphylococus aureus: A well-armed pathogen.
    59. (2002). Stereotyped and specific gene expression programs in human innate immune responses to bacteria.
    60. (2001). Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity.
    61. (2003). Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1.
    62. (2007). The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages.
    63. (2002). The Bcl2 family: regulators of the cellular life-ordeath switch.
    64. (2006). The role of NFkB-1 and NFkB2-mediated resistance to apoptosis in lymphomas.
    65. (2002). The role of STATs in apoptosis.
    66. (1952). The survival of staphylococci within human leukocytes.
    67. (2001). The VISA/GISA problem: therapeutic implication.
    68. (2005). Thorburn A
    69. (1998). Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis.
    70. (2001). Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
    71. (2001). Wilsson A

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.